Home › Long COVID › Alabama
Long COVID clinical trials in Alabama
5 studies for Long COVID are looking for participants at sites in Alabama.
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Birmingham
- Research Site, Mobile
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT05624450A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- University of Alabama at Birmingham, Huntsville Regional Medical Campus (HRMC), Huntsville
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Oct 15, 2026 · NCT06679140A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
- GSK Investigational Site, Anniston
RecruitingPhase 1
Ages 65 to 85 · All sexes · Updated Jun 30, 2026 · NCT07464314REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19
- University of Alabama at Birmingham, Birmingham
Recruiting
Ages 18 and older · All sexes · Updated May 28, 2026 · NCT05218083Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
- University of South Alabama, Mobile
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 28, 2021 · NCT04445285From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.